# Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute STEMI After Primary PCI

> **NCT03045562** · PHASE4 · UNKNOWN · sponsor: **Green Valley Group of China** · enrollment: 536 (estimated)

## Conditions studied

- STEMI - ST Elevation Myocardial Infarction

## Interventions

- **DRUG:** Normal saline
- **DRUG:** Salvianolate injection

## Key facts

- **NCT ID:** NCT03045562
- **Lead sponsor:** Green Valley Group of China
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-20
- **Primary completion:** 2018-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 536 (ESTIMATED)
- **Last updated:** 2017-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03045562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03045562, "Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute STEMI After Primary PCI". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT03045562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*